The global insulin delivery pen market is estimated to record a CAGR of 8.1% from 2024 to 2034. This is likely to take the ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point greater drop in HbA1c than controls. The AID group also spent 3.4 more hours ...

Scientists discover unique insulin responses in each person, opening new paths for early diabetes detection and treatment.

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.

in adults with insulin-treated type 2 diabetes. AID significantly lowered glycated hemoglobin (HbA1c) levels and improved glucose control compared to standard insulin therapy with continuous ...

Scientists have unearthed surprising details about how our bodies handle insulin—the hormone that plays a crucial role in ...

Type 2 diabetes accounts for approximately 90-95 ... Modern management options include: Multiple daily injections using insulin pens or syringes Insulin pump therapy delivering programmed amounts ...

AI-assisted insulin titration was noninferior to endocrinologists in managing glycemic control among patients with type 2 diabetes.

Artificial intelligence (AI) can enhance insulin dosing accuracy for hospitalized patients with type 2 diabetes (T2D), ...

Future medications that target this pathway and block the fat secretion from the liver could potentially prevent insulin-resistant adolescents from developing type 2 diabetes, the authors say.